Beverly Hills Cancer Center (BHCC)

Beverly Hills, California 90211

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration Resistant Prostate Cancer (mCRPC), Multiple Myeloma

Studies at this site

• A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer — Completed